☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - December 2022

December 19, 2022 at 9:05 am | In Prescribing Extra - Drugs | Print Print | No Comments

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Micronised progesterone (Utrogestan®) has been accepted for adjunctive use with oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT). This product provides an additional treatment choice in the therapeutic class of progestogens.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - December 2022' by emailShare 'SMC Update - December 2022' on FacebookShare 'SMC Update - December 2022' on TwitterShare 'SMC Update - December 2022' on MastodonShare 'SMC Update - December 2022' on LinkedInShare 'SMC Update - December 2022' on reddit

Copyright © 2022 Prescribing Advice for GPs

No Comments to “SMC Update - December 2022”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.